URO TODAY: Researchers in Canada have reviewed the vast range of drugs now being used to treatment prostate cancer. These include:
- drugs that induce androgen deprivation, that is, LHRH antagonists;
- more active or less toxic chemotherapy agents;
- immunologic approaches, including passive and active immunization;
- drugs that target the androgen receptor and/or androgen synthesis;
- drugs that target specific pathways, including tyrosine kinase inhibitors, angiogenesis inhibitors, endothelin antagonists and matrix metalloproteinase inhibitors;
- and antioxidants and cell cycle inhibitors.
READ MORE> (but note, you need to subscribe – that is, pay – to see the article).